Skip to main content
Erschienen in: Rheumatology International 8/2012

01.08.2012 | Short Communication

−383 A/C tumor necrosis factor receptor 1 polymorphism and ankylosing spondylitis in Mexicans: a preliminary study

verfasst von: Esther Guadalupe Corona-Sanchez, José Francisco Muñoz-Valle, Laura Gonzalez-Lopez, Julia Dolores Sanchez-Hernandez, Monica Vazquez-Del Mercado, Heriberto Ontiveros-Mercado, Miguel Huerta, Xochitl Trujillo, Alberto Daniel Rocha-Muñoz, Alfredo Celis, Ricardo Ortega-Flores, Jorge Ivan Gamez-Nava

Erschienen in: Rheumatology International | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to evaluate the differences in allele and genotype frequencies of −383 tumor necrosis factor receptor 1 (TNFR1) polymorphism between ankylosing spondylitis (AS) and controls. Mexican Mestizos with AS were matched by gender, age, and ethnicity with healthy controls and compared in allele and genotype frequencies of the −383 TNFR1 polymorphism. Polymorphisms were genotyped using PCR–RFLP. The AA genotype occurred at a higher frequency in the AS group (92%) compared with controls (79%, P = 0.03). A allele was increased in AS (96% vs. 88%, P = 0.015) and was associated with genetic susceptibility for AS (odds ratio = 3.48, 95% CI = 1.23–10.61). This preliminary study is the first assessing the association of the −383 A/C TNFR1 polymorphism with AS, although it has the limitation of a small sample size. These data are of interest for the genetic epidemiology of AS in the Mexican population, requiring further investigation in other countries.
Literatur
1.
Zurück zum Zitat Khan MA (1998) Ankylosing spondylitis: clinical aspects. In: Calin A, Taurog JD (eds) The spondylarthritides. Oxford University, Oxford, pp 27–40 Khan MA (1998) Ankylosing spondylitis: clinical aspects. In: Calin A, Taurog JD (eds) The spondylarthritides. Oxford University, Oxford, pp 27–40
2.
Zurück zum Zitat Liu Y, Cortinovis D, Stone MA (2004) Recent advances in the treatment of the spondyloarthropathies. Curr Opin Rheumatol 16:357–365PubMedCrossRef Liu Y, Cortinovis D, Stone MA (2004) Recent advances in the treatment of the spondyloarthropathies. Curr Opin Rheumatol 16:357–365PubMedCrossRef
3.
Zurück zum Zitat Glossop JR, Dawes PT, Nixon NB, Mattey DL (2005) Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Arthritis Res Ther 7:R1227–R1234PubMedCrossRef Glossop JR, Dawes PT, Nixon NB, Mattey DL (2005) Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Arthritis Res Ther 7:R1227–R1234PubMedCrossRef
4.
Zurück zum Zitat Dieudé P, Osorio J, Petit-Teixeira E et al (2004) A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum 50:413–419PubMedCrossRef Dieudé P, Osorio J, Petit-Teixeira E et al (2004) A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum 50:413–419PubMedCrossRef
5.
Zurück zum Zitat Glossop JR, Nixon NB, Dawes PT, Hassell AB, Mattey DL (2003) No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis. J Rheumatol 30:1406–1409PubMed Glossop JR, Nixon NB, Dawes PT, Hassell AB, Mattey DL (2003) No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis. J Rheumatol 30:1406–1409PubMed
6.
Zurück zum Zitat Pitts SA, Olomolaiye OO, Elson CJ, Westacott CI, Bidwell JL (1998) Identification of a rare Bg/II polymorphism in the promoter region of the human TNF receptor type I(p55) gene. Eur J Immunogenet 25:271–272PubMed Pitts SA, Olomolaiye OO, Elson CJ, Westacott CI, Bidwell JL (1998) Identification of a rare Bg/II polymorphism in the promoter region of the human TNF receptor type I(p55) gene. Eur J Immunogenet 25:271–272PubMed
7.
Zurück zum Zitat Nishimura M, Obayashi H, Mizuta I et al (2003) TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol 64:302–309PubMedCrossRef Nishimura M, Obayashi H, Mizuta I et al (2003) TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol 64:302–309PubMedCrossRef
8.
Zurück zum Zitat van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef
9.
Zurück zum Zitat Vargas-Alarcon G, Casasola-Vargas J, Rodríguez-Pérez JM et al (2006) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 67:826–832PubMedCrossRef Vargas-Alarcon G, Casasola-Vargas J, Rodríguez-Pérez JM et al (2006) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 67:826–832PubMedCrossRef
10.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
11.
Zurück zum Zitat Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed
12.
Zurück zum Zitat Daltroy LH, Larson MG, Roberts NW, Liang MH (1990) A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 17:946–950PubMed Daltroy LH, Larson MG, Roberts NW, Liang MH (1990) A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 17:946–950PubMed
13.
Zurück zum Zitat Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef
14.
Zurück zum Zitat Davis JC Jr (2005) Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis. Semin Arthritis Rheum 34:668–677PubMedCrossRef Davis JC Jr (2005) Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis. Semin Arthritis Rheum 34:668–677PubMedCrossRef
15.
Zurück zum Zitat Bridges SL Jr, Jenq G, Moran M, Kuffner T, Whitworth WC, McNicholl J (2002) Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences. Arthritis Rheum 46:2045–2050PubMedCrossRef Bridges SL Jr, Jenq G, Moran M, Kuffner T, Whitworth WC, McNicholl J (2002) Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences. Arthritis Rheum 46:2045–2050PubMedCrossRef
16.
Zurück zum Zitat Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA (2009) The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol 27:645–648PubMed Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA (2009) The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol 27:645–648PubMed
17.
Zurück zum Zitat Australo-Anglo-American Spondyloarthritis Consortium, TASC (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42:123–127CrossRef Australo-Anglo-American Spondyloarthritis Consortium, TASC (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42:123–127CrossRef
18.
Zurück zum Zitat Davidson SI, Liu Y, Danoy PA et al (2011) Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis 70:289–292PubMedCrossRef Davidson SI, Liu Y, Danoy PA et al (2011) Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis 70:289–292PubMedCrossRef
Metadaten
Titel
−383 A/C tumor necrosis factor receptor 1 polymorphism and ankylosing spondylitis in Mexicans: a preliminary study
verfasst von
Esther Guadalupe Corona-Sanchez
José Francisco Muñoz-Valle
Laura Gonzalez-Lopez
Julia Dolores Sanchez-Hernandez
Monica Vazquez-Del Mercado
Heriberto Ontiveros-Mercado
Miguel Huerta
Xochitl Trujillo
Alberto Daniel Rocha-Muñoz
Alfredo Celis
Ricardo Ortega-Flores
Jorge Ivan Gamez-Nava
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 8/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1997-5

Weitere Artikel der Ausgabe 8/2012

Rheumatology International 8/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.